Raphael Pharmaceutical Inc. SEC filings RAPH
Raphael Pharmaceutical Inc. has 179 filings in SEC EDGAR's recent list, going back to Oct 24, 2007. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 1, 2026 (material agreement). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement
|
Sep 1, 2026 | Jul 30, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 17, 2026 | Jul 16, 2026 |
| 8-K |
Current report
Officer or director change
|
Mar 24, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Officer or director change
|
Aug 11, 2025 | Jul 31, 2025 |
| 8-K |
Current report
Other events
|
Aug 11, 2025 | Aug 7, 2025 |
| 8-K |
Current report
Officer or director change
|
Jan 14, 2025 | Jan 8, 2025 |
| 8-K |
Current report
Other events
|
Dec 30, 2024 | Dec 23, 2024 |
| 8-K |
Current report
Auditor change
|
Sep 11, 2024 | Sep 5, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jun 26, 2024 | Jun 26, 2024 |
| 8-K |
Current report
Other events
|
May 2, 2024 | Apr 30, 2024 |
| 8-K |
Current report
Other events
|
Mar 28, 2023 | Mar 27, 2023 |
| 8-K/A |
Amended current report
Officer or director change
|
Jan 26, 2023 | Jul 7, 2022 |
| 8-K |
Current report
Other events
|
Oct 24, 2022 | Oct 7, 2022 |
| 8-K |
Current report
Auditor change, Officer or director change
|
Jul 7, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Auditor change
|
May 29, 2013 | May 29, 2013 |
| 8-K |
Current report
Unregistered share sale, Officer or director change
|
Oct 5, 2010 | Oct 5, 2010 |
| 8-K |
Current report
Officer or director change
|
Aug 25, 2010 | Aug 25, 2010 |
| 8-K |
Current report
Auditor change
|
Jan 20, 2010 | Jan 15, 2010 |
| 8-K/A |
Amended current report
Auditor change
|
Sep 10, 2009 | Aug 3, 2009 |
| 8-K |
Current report
Other events
|
Sep 4, 2009 | Aug 31, 2009 |
| 8-K |
Current report
Auditor change
|
Aug 6, 2009 | Aug 3, 2009 |
| 8-K/A | Amended current report | Jul 7, 2008 | Mar 10, 2008 |
| 8-K |
Current report
Unregistered share sale
|
Apr 3, 2008 | Apr 3, 2008 |
| 8-K |
Current report
Material agreement
|
Mar 24, 2008 | Mar 10, 2008 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Feb 13, 2008 | Feb 8, 2008 |
Showing 25 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- RAPH (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Las Vegas, NV
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1415397
- Former names
- Easy Energy Inc (until May 14, 2021)
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Source: SEC EDGAR filings. This is company-reported data, not investment advice.